venetoclax,obinutuzumab,Rituximab,Bendamustine,Ibrutinib
roche,abbvie,janssen
['venclexta', 'gazyva', 'leukemia']
venclexta plus gazyva led to better outcomes than chemoimmunotherapy in patients with chronic lymphocytic leukemia, according to research from #eha2022 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.